Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis

INTRODUCTION: The double-blind, phase 3 PREEMPT trials demonstrated the efficacy and tolerability of onabotulinumtoxinA for headache prevention in adults with chronic migraine. This post hoc analysis evaluated the effect of onabotulinumtoxinA on clinically meaningful changes in headache severity, he...

Descripción completa

Detalles Bibliográficos
Autores principales: Diener, Hans-Christoph, Dodick, David W., Lipton, Richard B., Manack Adams, Aubrey, DeGryse, Ronald E., Silberstein, Stephen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648806/
https://www.ncbi.nlm.nih.gov/pubmed/33026631
http://dx.doi.org/10.1007/s40122-020-00198-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648806/
https://www.ncbi.nlm.nih.gov/pubmed/33026631
http://dx.doi.org/10.1007/s40122-020-00198-w

Ejemplares similares